144 related articles for article (PubMed ID: 23232524)
1. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
[TBL] [Abstract][Full Text] [Related]
2. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
[TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
Shaker OG; Abdel-Rahim MT; Bayoumi ST
Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
[TBL] [Abstract][Full Text] [Related]
5. Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.
Ching JC; Chan KY; Lee EH; Xu MS; Ting CK; So TM; Sham PC; Leung GM; Peiris JS; Khoo US
J Infect Dis; 2010 Jun; 201(12):1899-908. PubMed ID: 20462354
[TBL] [Abstract][Full Text] [Related]
6. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
Hijikata M; Ohta Y; Mishiro S
Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
[TBL] [Abstract][Full Text] [Related]
7. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
8. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis.
Torisu H; Kusuhara K; Kira R; Bassuny WM; Sakai Y; Sanefuji M; Takemoto M; Hara T
Neurology; 2004 Feb; 62(3):457-60. PubMed ID: 14872030
[TBL] [Abstract][Full Text] [Related]
9. Association of rs2111485 and rs1990760 Polymorphisms of Interferon Induced with Helicase C Domain 1 Gene with Hepatitis C Virus Clearance in Chinese Han Population.
Jiang W; Zhuo L; Wu X; Shen J; Ye X; Wang Y; Xia X; Chen H; Yu R; Yang S; Huang P
Viral Immunol; 2019 Oct; 32(8):341-347. PubMed ID: 31539314
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
12. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
13. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
Shaker O; Ahmed A; Doss W; Abdel-Hamid M
J Viral Hepat; 2010 Nov; 17(11):794-9. PubMed ID: 20002306
[TBL] [Abstract][Full Text] [Related]
14. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
15. Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.
Zang F; Yue M; Yao Y; Liu M; Fan H; Feng Y; Xia X; Huang P; Yu R
Epidemiol Infect; 2018 Feb; 146(3):379-385. PubMed ID: 29271328
[TBL] [Abstract][Full Text] [Related]
16. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
[TBL] [Abstract][Full Text] [Related]
17. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
19. Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.
Fernández-Arcás N; Blanco A; Gaitán MJ; Nyqvist M; Alonso A; Reyes-Engel A
Pharmacogenetics; 2004 Mar; 14(3):189-93. PubMed ID: 15167707
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the
He M; Liu M; Geng J; Liu L; Huang P; Yue M; Xia X; Zhang AM
Front Cell Infect Microbiol; 2023; 13():1119805. PubMed ID: 36743306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]